Vascular Aging: A Central Driver Of Multimorbidity
As we age, our blood vessels undergo changes that are increasingly recognized as a central cause of many age-related health problems, not just heart disease. This process, known as vascular aging, involves several key biological mechanisms. For instance, “epigenetic drift” refers to changes in how our genes are expressed without altering the DNA sequence itself, impacting cell function. “Chronic low-grade inflammation” is a persistent, subtle inflammation throughout the body that damages tissues over time. “Cellular senescence” describes cells that stop dividing but remain active, releasing harmful substances that contribute to aging and disease. Additionally, problems with “mitochondrial dysfunction,” where the energy-producing parts of our cells don’t work efficiently, and “oxidative stress,” an imbalance between free radicals and antioxidants in the body, further accelerate this vascular decline. These changes can lead to stiffening of arteries and reduced blood flow, contributing to conditions like atherosclerosis (hardening of the arteries) and even Alzheimer’s disease. Researchers are exploring various strategies to combat vascular aging. These include repairing damage to the inner lining of blood vessels (endothelial injury), reducing inflammation and oxidative stress, and improving the function of mitochondria and protective caps on chromosomes called telomeres. Emerging treatments involve repurposed metabolic drugs, antioxidants that target mitochondria, and “senolytics,” which are compounds designed to selectively eliminate senescent cells. However, translating these discoveries into effective treatments for humans faces challenges, such as ensuring drugs reach the vascular wall effectively and finding reliable ways to measure treatment success in clinical trials. The future of addressing age-related diseases may lie in understanding and targeting these fundamental processes of vascular aging.
Source: link to paper